Development of solid lipid nanoparticles of diacerein in a stable oral liquid dosage form using a central composite design

References

• Almezgagi, M.; Zhang, Y.; Hezam, K.; Shamsan, E.; Gamah, M.; Al-Shaebi, F.; Abbas, A. B.; Shoaib, M.; Saif, B.; Han, Y.; et al. Diacerein: Recent Insight into Pharmacological Activities and Molecular Pathways. Biomed. Pharmacother. 2020, 131, 110594. DOI: 10.1016/j.biopha.2020.110594.
   PubMed Web of Science ®Google Scholar
• Pavelka, K.; Bruyère, O.; Cooper, C.; Kanis, J. A.; Leeb, B. F.; Maheu, E.; Martel-Pelletier, J.; Monfort, J.; Pelletier, J.-P.; Rizzoli, R.; et al. Diacerein: Benefits, Risks and Place in the Management of Osteoarthritis. An Opinion-Based Report from the ESCEO. Drugs Aging 2016, 33, 75–85. DOI: 10.1007/s40266-016-0347-4.
   PubMed Web of Science ®Google Scholar
• Ramos-Zavala, M. G.; González-Ortiz, M.; Martínez-Abundis, E.; Robles-Cervantes, J. A.; González-López, R.; Santiago-Hernández, N. J. Effect of Diacerein on Insulin Secretion and Metabolic Control in Drug-Naive Patients with Type 2 Diabetes: A Randomized Clinical Trial. Diabetes Care 2011, 34, 1591–1594. DOI: 10.2337/dc11-0357.
   PubMed Web of Science ®Google Scholar
• Bharti, R.; Dey, G.; Banerjee, I.; Dey, K. K.; Parida, S.; Kumar, B. N. P.; Das, C. K.; Pal, I.; Mukherjee, M.; Misra, M.; et al. Somatostatin Receptor Targeted Liposomes with Diacerein Inhibit IL-6 for Breast Cancer Therapy. Cancer Lett. 2017, 388, 292–302. DOI: 10.1016/j.canlet.2016.12.021.
   PubMed Web of Science ®Google Scholar
• Villar, M.; Martínez-Abundis, E.; Preciado-Márquez, R. O.; González-Ortiz, M. Effect of Diacerein as an Add-on to Metformin in Patients with Type 2 Diabetes Mellitus and Inadequate Glycemic Control. Arch. Endocrinol. Metab. 2017, 61, 188–192. DOI: 10.1590/2359-3997000000242.
   PubMed Web of Science ®Google Scholar
• Gandhi, S. P.; Dewani, M. G.; Borole, T. C.; Damle, M. C. Development and Validation of Stability Indicating HPTLC Method for Determination of Diacerein and Aceclofenac as Bulk Drug and in Tablet Dosage Form. J. Chem. 2012, 9, 2023–2028. DOI: 10.1155/2012/719264.
   Web of Science ®Google Scholar
• Petralito, S.; Zanardi, I.; Spera, R.; Memoli, A.; Travagli, V. Spectroscopic Characterization of Both Aqueous and Solid-State Diacerhein/Hydroxypropyl-β-Cyclodextrin Inclusion Complexes. Spectrochim. Acta. A Mol. Biomol. Spectrosc. 2014, 127, 355–360. DOI: 10.1016/j.saa.2014.02.055.
   PubMed Web of Science ®Google Scholar
• Rehman, M.; Madni, A.; Ihsan, A.; Khan, W. S.; Khan, M. I.; Mahmood, M. A.; Ashfaq, M.; Bajwa, S. Z.; Shakir, I. Solid and Liquid Lipid-Based Binary Solid Lipid Nanoparticles of Diacerein: In Vitro Evaluation of Sustained Release, Simultaneous Loading of Gold Nanoparticles, and Potential Thermoresponsive Behavior. Int. J. Nanomedicine 2015, 10, 2805–2814. DOI: 10.2147/IJN.S67147.
   PubMed Web of Science ®Google Scholar
• Jain, A.; Singh, S. K.; Singh, Y.; Singh, S. Development of Lipid Nanoparticles of Diacerein, an Antiosteoarthritic Drug for Enhancement in Bioavailability and Reduction in Its Side Effects. J. Biomed. Nanotechnol. 2013, 9, 891–900. DOI: 10.1166/jbn.2013.1580.
   PubMed Web of Science ®Google Scholar
• Gou, J.; Feng, S.; Liang, Y.; Fang, G.; Zhang, H.; Yin, T.; Zhang, Y.; He, H.; Wang, Y.; Tang, X. Polyester–Solid Lipid Mixed Nanoparticles with Improved Stability in Gastro-Intestinal Tract Facilitated Oral Delivery of Larotaxel. Mol. Pharm. 2017, 14, 3750–3761. DOI: 10.1021/acs.molpharmaceut.7b00503.
   PubMed Web of Science ®Google Scholar
• El-Laithy, H. M.; Basalious, E. B.; El-Hoseiny, B. M.; Adel, M. M. Novel Self-Nanoemulsifying Self-Nanosuspension (SNESNS) for Enhancing Oral Bioavailability of Diacerein: Simultaneous Portal Blood Absorption and Lymphatic Delivery. Int. J. Pharm. 2015, 490, 146–154. DOI: 10.1016/j.ijpharm.2015.05.039.
   PubMed Web of Science ®Google Scholar
• Elsayed, A.; Belal, A. Formulation, Characterization and in-Vitro Evaluation of Solid Lipid Nanoparticles for the Delivery of a New Anticancer Agent, 1 H-Pyrazolo[3,4-d] Pyrimidine Derivative. Trop. J. Pharm. Res. 2022, 20, 885–891. DOI: 10.4314/tjpr.v20i5.1.
   Web of Science ®Google Scholar
• Hao, J.; Wang, F.; Wang, X.; Zhang, D.; Bi, Y.; Gao, Y.; Zhao, X.; Zhang, Q. Development and Optimization of Baicalin-Loaded Solid Lipid Nanoparticles Prepared by Coacervation Method Using Central Composite Design. Eur. J. Pharm. Sci. 2012, 47, 497–505. DOI: 10.1016/j.ejps.2012.07.006.
   PubMed Web of Science ®Google Scholar
• Elsayed, A. M.; Al-Remawi, M.; Qinna, N.; Farouk, A.; Badwan, A. Formulation and Characterization of an Oily-Based System for Oral Delivery of Insulin. Eur. J. Pharm. Biopharm. 2009, 73, 269–279. DOI: 10.1016/j.ejpb.2009.06.004.
   PubMed Web of Science ®Google Scholar
• Pandya, N. T.; Jani, P.; Vanza, J.; Tandel, H. Solid Lipid Nanoparticles as an Efficient Drug Delivery System of Olmesartan Medoxomil for the Treatment of Hypertension. Colloids Surf. B Biointerfaces 2018, 165, 37–44. DOI: 10.1016/j.colsurfb.2018.02.011.
   PubMed Web of Science ®Google Scholar
• Abouelmagd, S. A.; Sun, B.; Chang, A. C.; Ku, Y. J.; Yeo, Y. Release Kinetics Study of Poorly Water-Soluble Drugs from Nanoparticles: Are we Doing It Right? Mol. Pharm. 2015, 12, 997–1003. DOI: 10.1021/mp500817h.
   PubMed Web of Science ®Google Scholar
• Sharma, D. K.; Gupta, V. K.; Kumar, S.; Joshi, V.; Mandal, R. S.; Prakash, A. G.; Singh, M. Evaluation of Antidiarrheal Activity of Ethanolic Extract of Holarrhena Antidysenterica Seeds in Rats. Vet. World 2015, 8, 1392–1395. DOI: 10.14202/vetworld.2015.1392-1395.
   PubMedGoogle Scholar
• Tadesse, E.; Engidawork, E.; Nedi, T.; Mengistu, G. Evaluation of the anti-Diarrheal Activity of the Aqueous Stem Extract of Lantana Camara Linn (Verbenaceae) in Mice. BMC Complement. Altern. Med. 2017, 17, 190. DOI: 10.1186/s12906-017-1696-1.
   PubMed Web of Science ®Google Scholar
• Rajati, F.; Ahmadi, N.; Naghibzadeh, Z. A.; Kazeminia, M. The Global Prevalence of Oropharyngeal Dysphagia in Different Populations: A Systematic Review and Meta-Analysis. J. Transl. Med. 2022, 20, 175. DOI: 10.1186/s12967-022-03380-0.
   PubMed Web of Science ®Google Scholar
• Kumar, R.; Singh, A.; Garg, N.; Siril, P. F. Solid Lipid Nanoparticles for the Controlled Delivery of Poorly Water Soluble Non-Steroidal anti-Inflammatory Drugs. Ultrason. Sonochem. 2018, 40, 686–696. DOI: 10.1016/j.ultsonch.2017.08.018.
   PubMed Web of Science ®Google Scholar
• Hou, D.; Xie, C.; Huang, K.; Zhu, C. The Production and Characteristics of Solid Lipid Nanoparticles (SLNs). Biomaterials 2003, 24, 1781–1785. DOI: 10.1016/s0142-9612(02)00578-1.
   PubMed Web of Science ®Google Scholar
• Diniz, F.; Marques, C.; Barbosa, T. C. Polymorphism, Crystallinity and Hydrophilic-Lipophilic Balance (HLB) of Cetearyl Alcohol and Cetyl Alcohol as Raw Materials for Solid Lipid Nanoparticles (SLN). Aspects Nanotechnol. 2018, 1, 52–60. DOI: 10.1016/j.colsurfb.2011.03.029.
   Google Scholar
• Nagasamy, V. D.; R, A.; Saraswathi, S.; Padma Priya, M. S.; Khan, N. I.; Kathirulla, N.; Sruthi, S. Dissolution Enhancement of Diacerein Using Water Soluble Carrier by Solid Dispersion Technology. J. Drug Delivery Ther. 2017, 7, 33–41. DOI: 10.22270/jddt.v7i5.1503.
   Google Scholar
• Gupta, N. V.; Gowda, D. V.; Balamuralidhara, V.; Khan, M. S. Preparation and Comparative Bioavailability Studies of Indomethacin-Loaded Cetyl Alcohol Microspheres. J. Pharm. (Cairo) 2013, 2013, 109837. DOI: 10.1155/2013/109837.
   PubMedGoogle Scholar
• Vankayala, J. S.; Battula, S. N.; Kandasamy, R.; Mariya, G. A.; Franklin, M. E. E.; Pushpadass, H. A.; Naik, L. N. Surfactants and Fatty Alcohol Based Novel Nanovesicles for Resveratrol: Process Optimization, Characterization, and Evaluation of Functional Properties in RAW 264.7 Macrophage Cells. J. Mol. Liq. 2018, 261, 387–396. DOI: 10.1016/j.molliq.2018.04.058.
   Web of Science ®Google Scholar
• Carletto, B.; Berton, J.; Ferreira, T. N.; Dalmolin, L. F.; Paludo, K. S.; Mainardes, R. M.; Farago, P. V.; Favero, G. M. Resveratrol-Loaded Nanocapsules Inhibit Murine Melanoma Tumor Growth. Colloids Surf. B Biointerfaces 2016, 144, 65–72. DOI: 10.1016/j.colsurfb.2016.04.001.
   PubMed Web of Science ®Google Scholar
• Pooja, D.; Panyaram, S.; Kulhar, H.; Rachamalla, S.; Ramakrishna, S. S.; Sistla, R. Xanthan Gum Stabilized Gold Nanoparticles: Characterization, Biocompatibility, Stability and Cytotoxicity. Carbohydr. Polym. 2014, 110, 1–9. DOI: 10.1016/j.carbpol.2014.03.041.
   PubMed Web of Science ®Google Scholar
• Rowe, R. C.; Sheskey, P. J.; Owen, S. C., eds. 2006. Handbook of Pharmaceutical Excipients. London: Pharmaceutical Press.
   Google Scholar
• Jain, S.; Nagori, B.; Yadav, S. Improvement of the Dissolution Behavior of the Poorly Water-Soluble Drug Diacerein by Solid Dispersion Technology and Its Formulation into Tablet Dosage Form. Madridge J. Nov. Drug Res. 2018, 2, 79–89. DOI: 10.18689/mjndr-1000112.
   Google Scholar
• Chin, C.-K.; Lee, J.-Y.; Lu, W.-S.; Brown, C. 2017. US Patent No. Appl. No 15/198,728: Pub. No. US 20170000732, San Diego, CA, U.S. Patent and Trademark Office.
   Google Scholar
• Talwar, M.; Dabre, R.; Verma, H.; Jain, N.; Jain, G. 2008. Orally disintegrating compositions of rhein or diacerein Appl. No. 12/934,122; Pub No. US 20110086070 A1, Delhi, India.
   Google Scholar
• Allam, A. N.; Hamdallah, S. I.; Abdallah, O. Y. Chitosan-Coated Diacerein Nanosuspensions as a Platform for Enhancing Bioavailability and Lowering Side Effects: Preparation, Characterization, and Ex Vivo/in Vivo Evaluation. Int. J. Nanomedicine 2017, 12, 4733–4745. DOI: 10.2147/IJN.S139706.
   PubMed Web of Science ®Google Scholar